PDS Biotechnology (PDSB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PDSB PDS Biotechnology

Watchlist

3.270
+0.010+0.31%

Close Apr 26 16:00 ET

3.360
+0.090+2.75%

Post 19:39 ET

119.94MMarket Cap-2352P/E (TTM)

Full Hours

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | PDS Biotech To Event To Discuss Positive, Updated Data From Phase 2 VERSATILE-002 Clinical Trial With Versamune HPV In Combination With KEYTRUDA In Recurrent Or Metastatic Head And Neck Cancer
Moomoo 24/7Apr 23 08:01 ET
PDS Biotechnology Corporation's (NASDAQ:PDSB) Market Cap Dropped US$1.5m Last Week; Individual Investors Who Hold 59% Were Hit as Were Institutions
Yahoo FinanceMar 30 08:35 ET
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 28 10:15 ET
Noble Financial Sticks to Its Buy Rating for PDS Biotechnology (PDSB)
TipRanksMar 28 08:25 ET
B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating
B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating.
MT NewswiresMar 28 07:57 ET
PDS Biotechnology: Strategic Shift to Triplet Therapy Promises Enhanced Clinical Success
TipRanksMar 28 07:25 ET

Comments

Meltyy

Jan 4 15:15

$XBI: Biotech Sector's Potential Outperformance in 2024, Especially Pre-Election Volatility in 1H

$SPDR S&P Biotech ETF(XBI.US)$
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...